The National Kidney Foundation (NFK) has launched a patient-friendly video series to help patients better understand the association between…
Andrea Lobo, PhD
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She has authored multiple research papers in peer-reviewed journals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
Certain self-reactive antibodies, called antiphospholipid antibodies (aPLs), significantly increase the risk of a heart attack, stroke, or other cardiovascular event…
This year’s winners of the Lupus Foundation of America‘s Gary S. Gilkeson Career Development Award — designed to support…
Lupus Therapeutics is partnering with AbbVie for the Phase 3 clinical program of upadacitinib for people with…
In a new deal worth up to $132.5 million, Everest Medicines will have the exclusive right to develop and commercialize…
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has awarded $3 million to a research team that’s…
A Canadian researcher will use a newly granted Lupus Canada Catalyst Award — with one year of funding totaling $40,000…
Toni Braxton is hoping to strike a chord with people with lupus via Aurinia Pharmaceuticals‘ “Get Uncomfortable” campaign:…
Viral infections with cytomegalovirus, known as CMV, are highly prevalent in children with systemic lupus erythematosus (SLE), and…
Progentec Diagnostics has partnered with GSK to launch PROACTIVE, a study to identify people at risk of developing…